Literature DB >> 22083953

RBFOX2 promotes protein 4.1R exon 16 selection via U1 snRNP recruitment.

Shu-Ching Huang1, Alexander C Ou, Jennie Park, Faye Yu, Brian Yu, Angela Lee, Guang Yang, Anyu Zhou, Edward J Benz.   

Abstract

The erythroid differentiation-specific splicing switch of protein 4.1R exon 16, which encodes a spectrin/actin-binding peptide critical for erythrocyte membrane stability, is modulated by the differentiation-induced splicing factor RBFOX2. We have now characterized the mechanism by which RBFOX2 regulates exon 16 splicing through the downstream intronic element UGCAUG. Exon 16 possesses a weak 5' splice site (GAG/GTTTGT), which when strengthened to a consensus sequence (GAG/GTAAGT) leads to near-total exon 16 inclusion. Impaired RBFOX2 binding reduces exon 16 inclusion in the context of the native weak 5' splice site, but not the engineered strong 5' splice site, implying that RBFOX2 achieves its effect by promoting utilization of the weak 5' splice site. We further demonstrate that RBFOX2 increases U1 snRNP recruitment to the weak 5' splice site through direct interaction between its C-terminal domain (CTD) and the zinc finger region of U1C and that the CTD is required for the effect of RBFOX2 on exon 16 splicing. Our data suggest a novel mechanism for exon 16 5' splice site activation in which the binding of RBFOX2 to downstream intronic splicing enhancers stabilizes the pre-mRNA-U1 snRNP complex through interactions with U1C.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083953      PMCID: PMC3255763          DOI: 10.1128/MCB.06423-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  Fox-2 splicing factor binds to a conserved intron motif to promote inclusion of protein 4.1R alternative exon 16.

Authors:  Julie L Ponthier; Christina Schluepen; Weiguo Chen; Robert A Lersch; Sherry L Gee; Victor C Hou; Annie J Lo; Sarah A Short; Joel A Chasis; John C Winkelmann; John G Conboy
Journal:  J Biol Chem       Date:  2006-03-14       Impact factor: 5.157

2.  Regulated Fox-2 isoform expression mediates protein 4.1R splicing during erythroid differentiation.

Authors:  Guang Yang; Shu-Ching Huang; Jane Y Wu; Edward J Benz
Journal:  Blood       Date:  2007-08-22       Impact factor: 22.113

3.  Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins.

Authors:  Zhen Zhi Tang; Sika Zheng; Julia Nikolic; Douglas L Black
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

4.  A functional association between the 5' and 3' splice site is established in the earliest prespliceosome complex (E) in mammals.

Authors:  S Michaud; R Reed
Journal:  Genes Dev       Date:  1993-06       Impact factor: 11.361

5.  Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.

Authors:  Anyu Zhou; Alexander C Ou; Aeri Cho; Edward J Benz; Shu-Ching Huang
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

6.  Tissue-specific alternative splicing of protein 4.1 inserts an exon necessary for formation of the ternary complex with erythrocyte spectrin and F-actin.

Authors:  W C Horne; S C Huang; P S Becker; T K Tang; E J Benz
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

7.  Mechanochemistry of the alternatively spliced spectrin-actin binding domain in membrane skeletal protein 4.1.

Authors:  D Discher; M Parra; J G Conboy; N Mohandas
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

8.  Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2.

Authors:  Chaolin Zhang; Zuo Zhang; John Castle; Shuying Sun; Jason Johnson; Adrian R Krainer; Michael Q Zhang
Journal:  Genes Dev       Date:  2008-09-15       Impact factor: 11.361

9.  An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells.

Authors:  Gene W Yeo; Nicole G Coufal; Tiffany Y Liang; Grace E Peng; Xiang-Dong Fu; Fred H Gage
Journal:  Nat Struct Mol Biol       Date:  2009-01-11       Impact factor: 15.369

10.  Tissue-specific splicing regulator Fox-1 induces exon skipping by interfering E complex formation on the downstream intron of human F1gamma gene.

Authors:  Kazuhiro Fukumura; Ayako Kato; Yui Jin; Takashi Ideue; Tetsuro Hirose; Naoyuki Kataoka; Toshinobu Fujiwara; Hiroshi Sakamoto; Kunio Inoue
Journal:  Nucleic Acids Res       Date:  2007-08-07       Impact factor: 16.971

View more
  21 in total

1.  Rbfox Proteins Regulate Splicing as Part of a Large Multiprotein Complex LASR.

Authors:  Andrey Damianov; Yi Ying; Chia-Ho Lin; Ji-Ann Lee; Diana Tran; Ajay A Vashisht; Emad Bahrami-Samani; Yi Xing; Kelsey C Martin; James A Wohlschlegel; Douglas L Black
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

2.  Protein 4.1R Exon 16 3' Splice Site Activation Requires Coordination among TIA1, Pcbp1, and RBM39 during Terminal Erythropoiesis.

Authors:  Shu-Ching Huang; Henry S Zhang; Brian Yu; Ellen McMahon; Dan T Nguyen; Faye H Yu; Alexander C Ou; Jennie Park Ou; Edward J Benz
Journal:  Mol Cell Biol       Date:  2017-04-14       Impact factor: 4.272

3.  Dysregulation of RBFOX2 Is an Early Event in Cardiac Pathogenesis of Diabetes.

Authors:  Curtis A Nutter; Elizabeth A Jaworski; Sunil K Verma; Vaibhav Deshmukh; Qiongling Wang; Olga B Botvinnik; Mario J Lozano; Ismail J Abass; Talha Ijaz; Allan R Brasier; Nisha J Garg; Xander H T Wehrens; Gene W Yeo; Muge N Kuyumcu-Martinez
Journal:  Cell Rep       Date:  2016-05-26       Impact factor: 9.423

Review 4.  Developmental regulation of RNA processing by Rbfox proteins.

Authors:  John G Conboy
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-10-17       Impact factor: 9.957

5.  Splicing Activation by Rbfox Requires Self-Aggregation through Its Tyrosine-Rich Domain.

Authors:  Yi Ying; Xiao-Jun Wang; Celine K Vuong; Chia-Ho Lin; Andrey Damianov; Douglas L Black
Journal:  Cell       Date:  2017-07-13       Impact factor: 41.582

6.  HnRNP A1 tethers KSRP to an exon splicing silencer that inhibits an erythroid-specific splicing event in PU.1-induced erythroleukemia.

Authors:  Alexandre Douablin; Mireille Deguillien; Osman Breig; Faouzi Baklouti
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

7.  RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues.

Authors:  Julian P Venables; Jean-Philippe Brosseau; Gilles Gadea; Roscoe Klinck; Panagiotis Prinos; Jean-François Beaulieu; Elvy Lapointe; Mathieu Durand; Philippe Thibault; Karine Tremblay; François Rousset; Jamal Tazi; Sherif Abou Elela; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2012-11-12       Impact factor: 4.272

Review 8.  RNA splicing during terminal erythropoiesis.

Authors:  John G Conboy
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

9.  CRISPR/Cas9 Genome Editing of the Human Topoisomerase IIα Intron 19 5' Splice Site Circumvents Etoposide Resistance in Human Leukemia K562 Cells.

Authors:  Victor A Hernandez; Jessika Carvajal-Moreno; Jonathan L Papa; Nicholas Shkolnikov; Junan Li; Hatice Gulcin Ozer; Jack C Yalowich; Terry S Elton
Journal:  Mol Pharmacol       Date:  2021-01-14       Impact factor: 4.436

10.  The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.

Authors:  Yifan Wang; Andrea J Bernhardy; Cristina Cruz; John J Krais; Joseph Nacson; Emmanuelle Nicolas; Suraj Peri; Hanneke van der Gulden; Ingrid van der Heijden; Shane W O'Brien; Yong Zhang; Maribel I Harrell; Shawn F Johnson; Francisco J Candido Dos Reis; Paul D P Pharoah; Beth Karlan; Charlie Gourley; Diether Lambrechts; Georgia Chenevix-Trench; Håkan Olsson; Javier J Benitez; Mark H Greene; Martin Gore; Robert Nussbaum; Siegal Sadetzki; Simon A Gayther; Susanne K Kjaer; Alan D D'Andrea; Geoffrey I Shapiro; David L Wiest; Denise C Connolly; Mary B Daly; Elizabeth M Swisher; Peter Bouwman; Jos Jonkers; Judith Balmaña; Violeta Serra; Neil Johnson
Journal:  Cancer Res       Date:  2016-05-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.